A Randomized Controlled Trail on the Efficacy of Topical Olopatadine Hydrochloride 0.1% and Ketotifen Fumarate 0.025% for the Relief of Symptoms of Vernal Keratoconjunctivitis. Medical Forum Monthly, [S. l.], v. 31, n. 8, 2020. Disponível em: https://medicalforummonthly.com/index.php/mfm/article/view/2404.. Acesso em: 10 jul. 2026.